Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-27 @ 1:01 AM
Study NCT ID:
NCT06102759
Status:
RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-10-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10-10
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-22
First Submit QC Date:
None
Study First Post Date:
2023-10-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-22
Last Update Post Date:
2023-10-26
Last Update Post Date Type:
ACTUAL